Table 4 Association between cardiac function parameters and pharmacological class of antipsychotics
Pharmacological class of antipsychotics | ||||
|---|---|---|---|---|
Monitoring parameters | First generation | Second generation | χ 2 | P-value |
Presence of ECG testing before AP treatment | 80 (21.5) | 200 (20.5) | 0.2 | 0.7 |
Presence of ECG testing during AP treatment | 101 (27.2) | 336 (34.4) | 6.5 | 0.01 |
Presence of electrolytes levels before AP treatment | 81 (21.8) | 214 (21.9) | 0.004 | 1 |
Presence of electrolytes levels during AP treatment | 100 (26.9) | 327 (33.5) | 5.5 | 0.02 |
Presence of personal history of pre-existing cardiac disease | 26 (7.0) | 40 (4.1) | 4.8 | 0.03 |
Number of cardiac function parameters tested | ||||
0 | 165 (44.4) | 437 (44.8) | 11.4a | 0.04a |
1 | 70 (18.8) | 152 (15.6) | ||
2 | 108 (29.0) | 258 (26.4) | ||
3 | 14 (3.8) | 71 (7.3) | ||
4 | 15 (4.0) | 50 (5.1) | ||
5 | 0 (0.0) | 8 (0.8) | ||